Insider · CIK 0001802639
Kevin Raymond Merrill Smith
ceopresidentofficerdirector
Files at INGN (Inogen Inc). First filing Mar 4, 2025, latest Mar 4, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$100k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
INGN: Inogen Inc
INGNOct 9, 2026 · close 6.18
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | INGN Inogen Inc | AGrant or award Common Stock10b5-1 | +1,500 | $5.33 | $7,995 | 134,962 | 39 d ago |
| Sep 1, 2025 | INGN Inogen Inc | AGrant or award Common Stock10b5-1 | +1,500 | $7.99 | $12k | 71,774 | Sep 3, 2025 |
| Mar 1, 2025 | INGN Inogen Inc | AGrant or award Common Stock10b5-1 | +1,500 | $8.33 | $12k | 16,054 | Mar 4, 2025 |
| Mar 1, 2025 | INGN Inogen Inc | MOption exercise Common Stock10b5-1 | +28,333 | $0.00 | $0 | 44,387 | Mar 4, 2025 |
| Mar 1, 2025 | INGN Inogen Inc | FTax withholding Common Stock10b5-1 | -13,700 | $8.33 | $114k | 30,687 | Mar 4, 2025 |
| Mar 1, 2025 | INGN Inogen Inc | AGrant or award Common Stock10b5-1 | +53,975 | $0.00 | $0 | 84,662 | Mar 4, 2025 |
| Mar 1, 2025 | INGN Inogen Inc | FTax withholding Common Stock10b5-1 | -26,097 | $8.33 | $217k | 58,565 | Mar 4, 2025 |
| Mar 3, 2025 | INGN Inogen Inc | POpen-market purchase Common Stock10b5-1 | +11,709 | $8.56 | $100k | 70,274 | Mar 4, 2025 |
| Feb 28, 2025 | INGN Inogen Inc | AGrant or award Restricted Stock Unitderivative10b5-1 | +90,036 | $0.00 | $0 | 90,036 | Mar 4, 2025 |
| Mar 1, 2025 | INGN Inogen Inc | MOption exercise Restricted Stock Unitderivative10b5-1 | -28,333 | $0.00 | $0 | 56,667 | Mar 4, 2025 |
| Dec 1, 2024 | INGN Inogen Inc | MOption exercise Common Stock | +28,333 | $0.00 | $0 | 28,333 | Dec 3, 2024 |
| Dec 1, 2024 | INGN Inogen Inc | FTax withholding Common Stock | -13,779 | $9.71 | $134k | 14,554 | Dec 3, 2024 |
| Dec 1, 2024 | INGN Inogen Inc | MOption exercise Restricted Stock Unitderivative | -28,333 | $0.00 | $0 | 56,667 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.